Markian Pryshliak

Heparan Sulfate Binding Coxsackievirus B3 Strain PD: A Novel Avirulent Oncolytic Agent Against Human Colorectal Carcinoma

Ahmet Hazini, Markian Pryshliak, Vanessa Brückner et al. · Human Gene Therapy · 2018 · 33 citations

Life Sciences, Infectious Diseases, Oncology +12

miR-375- and miR-1-Regulated Coxsackievirus B3 Has No Pancreas and Heart Toxicity But Strong Antitumor Efficiency in Colorectal Carcinomas

Ahmet Hazini, Babette Dieringer, Markian Pryshliak et al. · Human Gene Therapy · 2021 · 27 citations

Life Sciences, Molecular Biology, Oncology +16

Early Treatment of Coxsackievirus B3–Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy

Sandra Pinkert, Babette Dieringer, Robert Klopfleisch et al. · Circulation Heart Failure · 2019 · 25 citations

Life Sciences, Cardiology, Pharmacology +15

Anti-adenoviral Artificial MicroRNAs Expressed from AAV9 Vectors Inhibit Human Adenovirus Infection in Immunosuppressed Syrian Hamsters

Katrin Schaar, Anja Geisler, Milena Kraus et al. · Molecular Therapy — Nucleic Acids · 2017 · 24 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas

Sandra Pinkert, Markian Pryshliak, Kathleen Pappritz et al. · Cardiovascular Research · 2019 · 24 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +15